Trevena Inc (TRVN):企業の財務・戦略的SWOT分析

◆英語タイトル:Trevena Inc (TRVN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135526FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with standard diuretic therapy. Trevena’s TRV130 is an intravenous G protein biased ligand that targets the mu opioid receptor. The company’s GPCR is associated with beneficial versus adverse biological effects. Its TRV250 is an oral delta opioid biased ligand for treatment of refactory migraine. Trevena is headquartered in Chesterbrook, Pennsylvania, the US.

Trevena Inc Key Recent Developments

Mar 18,2021: Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
Mar 09,2021: Trevena reports fourth quarter and full year 2020 results
Mar 05,2021: Trevena to Release Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
Jan 07,2021: Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences
Sep 21,2020: Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting

This comprehensive SWOT profile of Trevena Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Trevena Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Trevena Inc – Key Information
Trevena Inc – Overview
Trevena Inc – Key Employees
Trevena Inc – Key Employee Biographies
Trevena Inc – Key Operational Heads
Trevena Inc – Major Products and Services
Trevena Inc – History
Trevena Inc – Company Statement
Trevena Inc – Locations And Subsidiaries
Trevena Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Trevena Inc – Business Description
Trevena Inc – Corporate Strategy
Trevena Inc – SWOT Analysis
SWOT Analysis – Overview
Trevena Inc – Strengths
Trevena Inc – Weaknesses
Trevena Inc – Opportunities
Trevena Inc – Threats
Trevena Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Trevena Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Trevena Inc, Key Information
Trevena Inc, Key Ratios
Trevena Inc, Share Data
Trevena Inc, Major Products and Services
Trevena Inc, History
Trevena Inc, Key Employees
Trevena Inc, Key Employee Biographies
Trevena Inc, Key Operational Heads
Trevena Inc, Other Locations
Trevena Inc, Subsidiaries
Trevena Inc, Key Competitors
Trevena Inc, SWOT Analysis
Trevena Inc, Ratios based on current share price
Trevena Inc, Annual Ratios
Trevena Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Trevena Inc (TRVN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets produc …
  • Takaful Emarat – Insurnace (P.S.C):企業の戦略・SWOT・財務情報
    Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report Summary Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務情報
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Orbit International Corp.:企業の戦略・SWOT・財務情報
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UCL Business PLC:企業のM&A・事業提携・投資動向
    UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCL Business PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Protagen AG-医療機器分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Desktop Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Desktop Genetics Ltd (DeskGen) is a provider of genome editing solutions. The company offers software solutions for the design, synthesis and assembly of DNA. It offers deskgen, which is a software system that helps scientists to organize, optimize, and automate their research. DeskGen’s CRI …
  • Tupperware Brands Corp (TUP):企業の財務・戦略的SWOT分析
    Tupperware Brands Corp (TUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vietnam Dairy Products Joint Stock Co:企業の戦略・SWOT・財務情報
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Schneider National Inc (SNDR):企業の財務・戦略的SWOT分析
    Schneider National Inc (SNDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Centice Corporation-製薬・医療分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • SIGA Technologies Inc (SIGA):企業の財務・戦略的SWOT分析
    Summary Siga Technologies Inc (Siga) a subsidiary of MacAndrews and Forbes Holdings Inc, is a health security service provider. The company develops and commercialise solutions for serious unmet medical needs and bio threats. It offers antiviral drug to treat smallpox disease. Siga offers product su …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …
  • Banco Santander-Chile:企業の戦略・SWOT・財務情報
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Lycatel Services Limited:企業の戦略的SWOT分析
    Lycatel Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆